An Vermeulen
- Food Science top 0.5%
- Molecular Biology top 10%
- Biomaterials top 2%
- Biotechnology top 0.5%
- Psychiatry and Mental health top 2%
- Co-authors
- Frank DevlieghereJohan DebevereMieke UyttendaeleJan Van BocxlaerKim StuyckensMahesh N. SamtaniJan Van ImpeAnnemie Geeraerd
- Topics
- Antibiotics Pharmacokinetics and Efficacy (25 papers)Schizophrenia research and treatment (24 papers)Listeria monocytogenes in Food Safety (21 papers)
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
An Vermeulen
215 papers receiving 4.8k citations
Hit Papers
Peers
Comparison fields: 5 of 174
- Food Science 1.0k
- Molecular Biology 905
- Biomaterials 677
- Biotechnology 626
- Psychiatry and Mental health 620
Countries citing papers authored by An Vermeulen
This map shows the geographic impact of An Vermeulen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Vermeulen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Vermeulen more than expected).
Fields of papers citing papers by An Vermeulen
This network shows the impact of papers produced by An Vermeulen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Vermeulen. The network helps show where An Vermeulen may publish in the future.
Co-authorship network of co-authors of An Vermeulen
This figure shows the co-authorship network connecting the top 25 collaborators of An Vermeulen. A scholar is included among the top collaborators of An Vermeulen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An Vermeulen. An Vermeulen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 5 | |
| 8 | 6 | |
| 9 | 10 | |
| 10 | 26 | |
| 11 | 27 | |
| 12 | 26 | |
| 13 | 2 | |
| 14 | Deoxynivalenol-3-β-D-glucoside : in vitro cytotoxicity and in vivo oral bioavailability and hydrolysis in broiler chicken and pig | 1 |
| 15 | 13 | |
| 16 | 13 | |
| 17 | 50 | |
| 18 | Predictive models to support manufacturers of processed meat in their compliance with EU regulation 2073/2005 | 2 |
| 19 | Photocatalytic degradation of the antibiotic moxifloxacin: a deeper look at the degradation products and residual antibacterial activity | 1 |
| 20 | Evaluation of growth/no growth modelling approaches on a non-abrupt growth/no growth interface of Listeria monocytogenes | 3 |
About An Vermeulen
An Vermeulen is a scholar working on Biotechnology, Pharmacology and Pharmacology, having authored 222 papers that have together received 5.0k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (25 papers), Schizophrenia research and treatment (24 papers) and Listeria monocytogenes in Food Safety (21 papers). The work is most often cited by research in Biotechnology (626 citations), Food Science (1.0k citations) and Biomaterials (677 citations). An Vermeulen has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Frank Devlieghere, Johan Debevere, Mieke Uyttendaele, Jan Van Bocxlaer, Kim Stuyckens, Mahesh N. Samtani, Jan Van Impe, Annemie Geeraerd, Robert Paridaens and J.P. Deslypère. Their work appears in journals such as JAMA, Journal of Clinical Oncology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.